Ligand Pharmaceuticals | Umlaufvermögen

Aktienkurs
198.31
Täglich Wechseln
2.14 1.09%
Monatlich
4.25%
Jährlich
62.24%
Q1 Prognose
192.24




Umlaufvermögen Veränderung Datum
Agenus USD 133.95M 120.61M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Baxter International USD 6.87B 61M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Enviri Corporation USD 769.24M 21.36M 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Merck USD 47.56B 10.49B 2025-09
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 488.38M 39.15M 2025-12


Ligand Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.